Harvard: AI may help solve healthcare's red-tape problem

Artificial intelligence may help stop the “downward spiral in productivity” in the healthcare system that has been plagued by labor-intensive, inefficient administrative tasks, according to an article in the Harvard Business Review.

AI tools capable of processing vast amounts of data and making real-time recommendations could greatly reduce the administrative burdens in the healthcare system––and save money to boot. According to the article, about one-third of the $3 trillion annual costs of the U.S. healthcare system are administrative and operational inefficiencies.

Unlike the “Herculean effort” of adopting electronic health records, adopting AI is different.

“Where EHRs required billions of dollars in investment and multi-year commitments from health systems, AI is more about targeted solutions,” wrote Minoo Javanmardian, PhD, partner of health and life sciences at Oliver Wyman Health; and Aditya Lingampally, principal of health and life sciences at Oliver Wyman Health. “It involves productivity improvements made in increments by individual organizations without the prerequisite collaboration and standardization across health care players required with EHR adoption.”

Specifically, AI is enabling:

  • Faster hospital bed assignments
  • Easier and improved documentation
  • Automated fraud detection

As AI continues to be adopted into the healthcare space, providers can expect more capabilities to ease inefficiencies, improve care and reduce costs.

See the full story below:

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

Given the precarious excitement of the moment—or is it exciting precarity?—policymakers and healthcare leaders must set directives guiding not only what to do with AI but also when to do it. 

The final list also included diabetes drugs sold by Boehringer Ingelheim and Merck. The first round of drug price negotiations reduced the Medicare prices for 10 popular drugs by up to 79%. 

HHS has thought through the ways AI can and should become an integral part of healthcare, human services and public health. Last Friday—possibly just days ahead of seating a new secretary—the agency released a detailed plan for getting there from here.